Foreign Direct Investment

Jianwei (Jerry) Fang, Chao (David) Lv and Runyang Liu of Zhong Lun Law Firm highlight the newly revised regulatory measures for medical devices business enterprises and discuss heightened compliance requirements.

Lawyers also say U.S.-China trade tensions could be further damaged by "reverse CFIUS," a proposed law under which the U.S. government could prohibit investments into China it deems a threat to certain domestic capabilities.

PCAOB and Beijing reach audit agreement to prevent mass delisting; U.S.-China merger abandoned following U.S. antitrust investigation; new compliance rules for wealth management companies

Loan prime rates slightly lowered; 3-year development blueprint for the Lingang Free Trade Zone unveiled; New rules on exercise of administrative discretion

Foreign investors have the same shareholding cap as domestic investors in insurance asset management companies.

A U.S. company acquiring a Chinese company will face a multitude of regulatory restrictions and requirements. How can the U.S. acquirer manage the risk of the deal being blocked or unwound for non-compliance?

CFIUS publishes data from 2021; Autonomous vehicles can be driven in simple and controlled conditions; Trust firms' loans to real estate sector audited

Foreign institutional investors may engage in trading in open-ended bond index securities investment funds

Self-assessment is required before filing for security assessment of data transfer.